| Date | Title | Description |
| 01.07.2025 | Inhalation Sciences receives service order from recurring global pharmaceutical customer | Inhalation Sciences receives service order from recurring global pharmaceutical customer
Tue, Jul 01, 2025 10:00 CET Report this content
Stockholm, July 1, 2025 - Inhalation Sciences Sweden AB (ISAB) today announces that the company has rec... |
| 28.05.2025 | Inhalation Sciences AB: Navigating Challenges and Embracing Growth in 2024 | Inhalation Sciences AB (ISAB) stands at a crossroads. The company recently released its Annual Report for 2024, revealing a landscape marked by both challenges and opportunities. The report, available on their website, paints a picture of a... |
| 28.05.2025 | Inhalation Sciences Expands Horizons: Strategic Moves in the U.S. Market | Inhalation Sciences AB (ISAB) is making waves in the world of respiratory research. The company, based in Stockholm, has recently signed a strategic agreement with BioLum Sciences, a U.S.-based firm specializing in inhalation diagnostics. T... |
| 28.05.2025 | Inhalation Sciences: Breathing New Life into Respiratory Research | Inhalation Sciences AB (ISAB) is making waves in the world of respiratory research. The company, based in Sweden, is on a mission to transform how inhalation studies are conducted. With its innovative technologies, ISAB is poised to reshape... |
| 27.05.2025 | Inhalation Sciences appoints Ulf Wedenberg as Chief Commercial Officer (CCO) | Inhalation Sciences appoints Ulf Wedenberg as Chief Commercial Officer (CCO)
Tue, May 27, 2025 08:00 CET Report this content
Stockholm, May 27, 2025 - Inhalation Sciences Sweden AB (ISAB) has recruited Ulf Wedenberg as its new Chief Commerc... |
| 27.05.2025 | Inhalation Sciences AB (publ) releases Annual Report 2024 | Inhalation Sciences AB (publ) releases Annual Report 2024
Tue, May 27, 2025 14:00 CET Report this content
Inhalation Sciences AB announces that its Annual Report for 2024 is now available on the company's website.
To read the whole report (... |
| 22.05.2025 | Inhalation Sciences Signs Strategic Agreement with U.S.-based BioLum Sciences, expanding U.S. Presence & Commercial Reach to Advance In Vitro Respiratory Research | Inhalation Sciences Signs Strategic Agreement with U.S.-based BioLum Sciences, expanding U.S. Presence & Commercial Reach to Advance In Vitro Respiratory Research
Thu, May 22, 2025 08:30 CET Report this content
Stockholm, May 22, 2025 -... |
| 08.05.2025 | Inhalation Sciences receives new IRS orders from returning customers – increased demand in line with regulatory requirements | Inhalation Sciences receives new IRS orders from returning customers – increased demand in line with regulatory requirements
Thu, May 08, 2025 08:30 CET Report this content
Stockholm, May 8, 2025 - Inhalation Sciences AB (ISAB) today announ... |
| 24.04.2025 | Inhalation Sciences AB reports positive primary and secondary study results in the FDA-funded study of DissolvIt® and receives approval from the FDA to publish the study results | Inhalation Sciences AB reports positive primary and secondary study results in the FDA-funded study of DissolvIt® and receives approval from the FDA to publish the study results
Thu, Apr 24, 2025 08:00 CET Report this content
Stockholm, Swe... |
| 15.04.2025 | Inhalation Sciences receives new order worth 41,000 Euro from returning big pharma customer | Inhalation Sciences receives new order worth 41,000 Euro from returning big pharma customer
Tue, Apr 15, 2025 08:35 CET Report this content
Stockholm, Sweden – April 15, 2025 – Inhalation Sciences AB (ISAB) has received a purchase order fro... |
| 07.03.2025 | Inhalation Sciences AB: Navigating Challenges and Seizing Opportunities in 2025 | Inhalation Sciences AB (ISAB) stands at a crossroads. The company, based in Stockholm, Sweden, recently released its Year-End Report for 2024, revealing a landscape marked by both challenges and potential. As the sun sets on a year of slow ... |
| 03.03.2025 | Inhalation Sciences well-positioned as FDA emphasizes dissolution testing for inhalation studies | Inhalation Sciences well-positioned as FDA emphasizes dissolution testing for inhalation studies
Mon, Mar 03, 2025 10:35 CET Report this content
Stockholm, Sweden – March 3, 2025 – Inhalation Sciences AB (ISAB), a leader in inhalation resea... |
| 28.02.2025 | Inhalation Sciences AB (publ) releases Q4 / Year-End Report 2024 | Inhalation Sciences AB (publ) releases Q4 / Year-End Report 2024
Fri, Feb 28, 2025 08:30 CET Report this content
(Stockholm, Sweden, 28 February 2025) Inhalation Sciences AB announces that its Q4 / Year-End Report for 2024 is now available ... |
| 13.01.2025 | Inhalation Sciences’ launch of the XposeALI[®] in vitro module with microperfusion | Inhalation Sciences’ launch of the XposeALI[®] in vitro module with microperfusion
Mon, Jan 13, 2025 08:30 CET Report this content
(Stockholm, Sweden, 13 January 2025) Inhalation Sciences (ISAB) announces its plans to launch the company’s X... |
| 10.01.2025 | Inhalation Sciences: Pioneering the Future of Inhalation Therapy | Inhalation Sciences Sweden AB (ISAB) is making waves in the pharmaceutical industry. With recent submissions to the FDA and new orders from global clients, the company is at the forefront of inhalation therapy development. Their innovative ... |
| 10.01.2025 | Inhalation Sciences receives IRS order worth SEK 212,000 from global leader in generics and biosimilars | Inhalation Sciences receives IRS order worth SEK 212,000 from global leader in generics and biosimilars
Fri, Jan 10, 2025 08:30 CET Report this content
(Stockholm, Sweden, 10 January 2025) Inhalation Sciences AB (ISAB) has received an order... |
| 09.01.2025 | Inhalation Sciences submits Project Report and Summary Data to the FDA for Final Review | Inhalation Sciences submits Project Report and Summary Data to the FDA for Final Review
Thu, Jan 09, 2025 08:30 CET Report this content
(Stockholm, Sweden, 9 January 2025) Inhalation Sciences Sweden AB (ISAB) is proud to announce the submis... |
| 17.12.2024 | Inhalation Sciences receives new orders totalling 33,900 Euro for technical service contracts | Inhalation Sciences receives new orders totalling 33,900 Euro for technical service contracts
Tue, Dec 17, 2024 11:32 CET Report this content
(Stockholm, Sweden, 17 December 2024) Inhalation Sciences AB (publ), a world-leading research and ... |
| 20.11.2024 | Inhalation Sciences AB (publ) releases Q3 Report 2024 | Inhalation Sciences AB (publ) releases Q3 Report 2024
Wed, Nov 20, 2024 08:30 CET Report this content
(Stockholm, Sweden, 20 November, 2024) Inhalation Sciences AB announces that its Q3 Report for 2024 is now available on the company's webs... |
| 16.10.2024 | A Surge in Scientific Innovation: SEK 835 Million in Grants Fueling Research Breakthroughs | In a world where knowledge is power, the Knut and Alice Wallenberg Foundation is igniting the flames of scientific discovery. With a staggering SEK 835 million allocated to 30 groundbreaking research projects, the foundation is setting the ... |
| 16.10.2024 | Inhalation Sciences provides latest status update on ongoing FDA BAA dissolution research project | Inhalation Sciences provides latest status update on ongoing FDA BAA dissolution research project
Wed, Oct 16, 2024 08:30 CET Report this content
(Stockholm, 16 October 2024) Inhalation Sciences Sweden AB (ISAB) today releases the latest up... |
| 10.10.2024 | Publication of positive performance of ISAB’s in vitro module demonstrated in collaboration with Karolinska Institutet | Publication of positive performance of ISAB’s in vitro module demonstrated in collaboration with Karolinska Institutet
Thu, Oct 10, 2024 08:30 CET Report this content
A new publication demonstrates how XposeALI®, Inhalation Sciences’ in vit... |
| 28.08.2024 | Inhalation Sciences AB (publ) releases Q2 Report 2024 | Inhalation Sciences AB (publ) releases Q2 Report 2024
Wed, Aug 28, 2024 08:30 CET Report this content
(Stockholm, Sweden, 28 August 2024) Inhalation Sciences AB announces that its Q2 Report for 2024 is now available on the company’s website... |
| 15.08.2024 | Surge of new orders totalling 50,000 Euro signals new sales season for Inhalation Research Services | Surge of new orders totalling 50,000 Euro signals new sales season for Inhalation Research Services
Thu, Aug 15, 2024 08:30 CET Report this content
(Stockholm, 15 August 2024) Inhalation Sciences AB (ISAB) has received a surge of new orders... |
| 12.08.2024 | Forthcoming changes in Inhalation Sciences’ Board of Directors | Forthcoming changes in Inhalation Sciences’ Board of Directors
Mon, Aug 12, 2024 12:56 CET Report this content
Inhalation Sciences Sweden AB’s (publ) (“Inhalation Sciences” or the “Company”) Nomination Committee proposes that Ulf Ericsson b... |
| 13.06.2024 | Inhalation Sciences receives new IRS order for DissolvIt® study worth 57,000 Euro from leading inhalation big pharma | Inhalation Sciences receives new IRS order for DissolvIt® study worth 57,000 Euro from leading inhalation big pharma
Thu, Jun 13, 2024 10:35 CET Report this content
(Stockholm, 13 June 2024) Inhalation Sciences AB (ISAB) has received its fi... |
| 29.05.2024 | Watch ISAB CEO go behind the headlines in high-value Q1 interview | Watch ISAB CEO go behind the headlines in high-value Q1 interview
Wed, May 29, 2024 11:52 CET Report this content
Inhalation Sciences CEO Manoush Masarrat discusses the company’s recent Q1 Report, and takes investors’ questions, in the firs... |
| 28.05.2024 | Inhalation Sciences AB (publ) releases Q1 Report 2024 | Inhalation Sciences AB (publ) releases Q1 Report 2024
Tue, May 28, 2024 08:00 CET Report this content
(Stockholm, Sweden, 28 May 2024) Inhalation Sciences AB announces that its Q1 Report for 2024 is now available on the company’s website.
T... |
| 22.05.2024 | Inhalation Sciences presents at well-received FDA public workshop GDUFA | Inhalation Sciences presents at well-received FDA public workshop GDUFA
Wed, May 22, 2024 11:08 CET Report this content
On 20 May Inhalation Sciences AB CSO Per Gerde presented the company’s predictive tools for developing and assessing gen... |
| 21.05.2024 | Inhalation Sciences receives new order worth 60,000 Euro from long-term big pharma client | Inhalation Sciences receives new order worth 60,000 Euro from long-term big pharma client
Tue, May 21, 2024 10:00 CET Report this content
Inhalation Sciences AB (ISAB) has received a purchase order worth 60,000 EURO (almost 700,000 SEK) fro... |
| 11.04.2024 | Inhalation Sciences AB (publ) releases Annual Report 2023 | Inhalation Sciences AB (publ) releases Annual Report 2023
Thu, Apr 11, 2024 08:30 CET Report this content
Inhalation Sciences AB announces that its Annual Report for 2023 is now available on the company’s website.
To read the whole report (... |
| 10.04.2024 | Inhalation Sciences to present at FDA’s public workshop GDUFA on May 20th, 2024 | Inhalation Sciences to present at FDA’s public workshop GDUFA on May 20th, 2024
Wed, Apr 10, 2024 08:30 CET Report this content
Inhalation Sciences Sweden AB (ISAB) has been invited to provide a public comments presentation at the FDA’s pub... |
| 11.03.2024 | Positive results of first-in-human clinical trial of PreciseInhale now published in European Journal of Pharmaceutical Sciences | Positive results of first-in-human clinical trial of PreciseInhale now published in European Journal of Pharmaceutical Sciences
Mon, Mar 11, 2024 08:30 CET Report this content
(Stockholm, 11 March 2024) Positive results from Inhalation Scie... |
| 28.02.2024 | Inhalation Sciences AB (publ) releases Q4 / YE Report | Inhalation Sciences AB (publ) releases Q4 / YE Report
Wed, Feb 28, 2024 08:30 CET Report this content
(Stockholm, Sweden, 28 February 2024) Inhalation Sciences AB announces that its Q4 / Year End Report for 2023 is now available on the comp... |
| 28.02.2024 | Inhalation Sciences AB (publ) releases Q4 / YE Report | Inhalation Sciences AB (publ) releases Q4 / YE Report
Wed, Feb 28, 2024 08:30 CET Report this content
(Stockholm, Sweden, 28 March, 2024) Inhalation Sciences AB announces that its Q4 / Year End Report for 2023 is now available on the compan... |
| 22.01.2024 | Inhalation Sciences signs new partnership with Actarmo Medical: End-to-end offering for respiratory drug development Services | Inhalation Sciences signs new partnership with Actarmo Medical: End-to-end offering for respiratory drug development Services
Mon, Jan 22, 2024 08:30 CET Report this content
Inhalation Sciences AB (ISAB) has signed a new partnership with fe... |
| 29.12.2023 | Inhalation Sciences secures product service contract worth 47,000 Euro | Inhalation Sciences secures product service contract worth 47,000 Euro
Fri, Dec 29, 2023 08:30 CET Report this content
(Stockholm, Sweden, 29 December,2023) Inhalation Sciences AB (ISAB) has secured a product service contract with a worth o... |
| 13.12.2023 | Inhalation Sciences’ captures interest and interaction at its latest industry webinar ‘Inhaled Biologics’ | Inhalation Sciences’ captures interest and interaction at its latest industry webinar ‘Inhaled Biologics’
Wed, Dec 13, 2023 10:37 CET Report this content
(Stockholm, Sweden, 13 December 2023) Interest and interaction was high on December 11... |
| 22.11.2023 | Inhalation Sciences AB (publ) releases Q3 Report 2023 | Inhalation Sciences AB (publ) releases Q3 Report 2023
Wed, Nov 22, 2023 08:30 CET Report this content
(Stockholm, Sweden, 29 August,2023) Inhalation Sciences AB announces that its Q3 Report for 2023 is now available on the company’s website... |
| 13.11.2023 | Inhalation Sciences wins new purchase order worth 276,450 Euro (3.2 MSEK) | Inhalation Sciences wins new purchase order worth 276,450 Euro (3.2 MSEK)
Mon, Nov 13, 2023 08:30 CET Report this content
(Stockholm, Sweden, 13 November,2023) Inhalation Sciences AB has received a new purchase order worth 276,450 Euro from... |
| 08.11.2023 | Inhalation Sciences secures new order worth 54,700 Euro | Inhalation Sciences secures new order worth 54,700 Euro
Wed, Nov 08, 2023 08:30 CET Report this content
(Stockholm, Sweden, 8 November,2023) Inhalation Sciences AB has signed a new order valued at 54,700 Euro with a customer in Europe devel... |
| 31.10.2023 | Inhalation Sciences’ CEO at Redeye Life Science Day 2023 | Inhalation Sciences’ CEO at Redeye Life Science Day 2023
Tue, Oct 31, 2023 14:16 CET Report this content
Join Inhalation Sciences AB (ISAB) CEO Manoush Masarrat for a 2-minute company pitch and 20-minute analyst Q&A at the livestreamed ... |
| 18.10.2023 | Inhalation Sciences strengthens its US IP position with new patent approval | Inhalation Sciences strengthens its US IP position with new patent approval
Wed, Oct 18, 2023 08:30 CET Report this content
(Stockholm, October 18, 2023) Innovative Swedish MedTech company Inhalation Sciences Sweden AB (ISAB) has strengthen... |
| 16.10.2023 | Inhalation Sciences secures 188,900 Euro order from top-five global generics manufacturer | Inhalation Sciences secures 188,900 Euro order from top-five global generics manufacturer
Mon, Oct 16, 2023 08:30 CET Report this content
Inhalation Sciences AB (ISAB) has been awarded a new order from a returning customer for an Inhalation... |
| 29.09.2023 | Inhalation Sciences signs collaboration agreement with leading Indian multinational pharma company | Inhalation Sciences signs collaboration agreement with leading Indian multinational pharma company
Fri, Sep 29, 2023 08:52 CET Report this content
Inhalation Sciences AB (ISAB) has signed a collaboration agreement with a leading Indian mult... |
| 29.08.2023 | Inhalation Sciences AB (publ) releases Q2 Report 2023 | Inhalation Sciences AB (publ) releases Q2 Report 2023
Tue, Aug 29, 2023 08:30 CET Report this content
(Stockholm, Sweden, 29 August,2023) Inhalation Sciences AB announces that its Q2 Report for 2023 is now available on the company’s website... |
| 23.08.2023 | Inhalation Sciences AB (publ) to repay its loan by end of August 2023 | Inhalation Sciences AB (publ) to repay its loan by end of August 2023
Wed, Aug 23, 2023 08:46 CET Report this content
(Stockholm, Sweden, 23 August 2023) Inhalation Sciences AB will repay a 1.8 MSEK loan which was reported in the Q1 Report ... |
| 28.06.2023 | Inhalation Sciences wins new Purchase Order from Asian distributor worth 94,000 USD | Inhalation Sciences wins new Purchase Order from Asian distributor worth 94,000 USD
Wed, Jun 28, 2023 13:00 CET Report this content
Inhalation Sciences AB (ISAB) has received a new Purchase Order worth 94,000 USD, or just over 1 million SEK... |
| 27.06.2023 | Inhalation Sciences receives Purchase Order worth 125.8 KEURO from international distributor for Asia | Inhalation Sciences receives Purchase Order worth 125.8 KEURO from international distributor for Asia
Tue, Jun 27, 2023 08:30 CET Report this content
Inhalation Sciences AB (ISAB) has received a Purchase Order, worth 125.8 KEuro (1.47 MSEK)... |
| 21.06.2023 | Inhalation Research Services wins new order worth 98,000 Euro from returning US customer | Inhalation Research Services wins new order worth 98,000 Euro from returning US customer
Wed, Jun 21, 2023 08:30 CET Report this content
Inhalation Sciences AB (ISAB) has received a new order for an Inhalation Research Services (IRS) projec... |
| 31.05.2023 | Inhalation Sciences AB (publ) releases Q1 Report 2023 | Inhalation Sciences AB (publ) releases Q1 Report 2023
Wed, May 31, 2023 08:00 CET Report this content
(Stockholm, Sweden, 31 May 2023) Inhalation Sciences AB announces that its Q1 Report for 2023 is now available on the company’s website. T... |
| 25.05.2023 | Inhalation Sciences receives 125,000 EURO funding in cross-European research project on inhaled antibiotics and antibiotic resistance | Inhalation Sciences receives 125,000 EURO funding in cross-European research project on inhaled antibiotics and antibiotic resistance
Thu, May 25, 2023 08:30 CET Report this content
(Stockholm, 25 May, 2023) Inhalation Sciences (ISAB) has b... |
| 22.05.2023 | Inhalation Sciences receives new order worth 53,000 Euro from returning customer | Inhalation Sciences receives new order worth 53,000 Euro from returning customer
Mon, May 22, 2023 08:30 CET Report this content
Inhalation Sciences AB (ISAB) has received a new order worth 53,000 Euro from a regular client – a large global... |
| 05.05.2023 | Inhalation Sciences receives green light from the US FDA to start the experimental phase of FDA BAA dissolution research project | Inhalation Sciences receives green light from the US FDA to start the experimental phase of FDA BAA dissolution research project
Fri, May 05, 2023 08:30 CET Report this content
(Stockholm, 05 May 2023) Following its communication on April 1... |
| 04.05.2023 | Inhalation Sciences: close to 200 register for latest expert’s webinar - now available online | Inhalation Sciences: close to 200 register for latest expert’s webinar - now available online
Thu, May 04, 2023 10:38 CET Report this content
(Stockholm, Sweden, 4 May 2023) Almost 200 specialists registered for ISAB’s latest experts’ webin... |
| 19.04.2023 | Inhalation Sciences ramps up popular expert webinar series with new release on May 2[nd], 2023 | Inhalation Sciences ramps up popular expert webinar series with new release on May 2[nd], 2023
Wed, Apr 19, 2023 10:34 CET Report this content
(Stockholm, Sweden, 19 April 2023) Following its highly successful webinar on DissolvIt dissoluti... |
| 18.04.2023 | Inhalation Sciences completes all preparations for FDA BAA dissolution research project | Inhalation Sciences completes all preparations for FDA BAA dissolution research project
Tue, Apr 18, 2023 08:30 CET Report this content
(Stockholm, 18 April 2023) Inhalation Sciences Sweden AB (ISAB) has completed all the required administr... |
| 11.04.2023 | Inhalation Sciences AB (publ) releases Annual Report 2022 including Audit Report | Inhalation Sciences AB (publ) releases Annual Report 2022 including Audit Report
Tue, Apr 11, 2023 11:54 CET Report this content
(Stockholm, Sweden, 11 April 2023) Inhalation Sciences AB announces that it is now releasing an updated version... |
| 11.04.2023 | Inhalation Sciences AB (publ) releases Annual Report 2022 | Inhalation Sciences AB (publ) releases Annual Report 2022
Tue, Apr 11, 2023 08:30 CET Report this content
(Stockholm, Sweden, 11 April 2023) Inhalation Sciences AB announces that its Annual Report for 2022 is now available on the company’s ... |
| 21.03.2023 | Inhalation Sciences receives IRS order worth 35,000 Euro from global generics company | Inhalation Sciences receives IRS order worth 35,000 Euro from global generics company
Tue, Mar 21, 2023 13:55 CET Report this content
Inhalation Sciences AB (ISAB) has received an order from a new client, a global generics company, for an I... |
| 07.03.2023 | Inhalation Sciences AB (publ) presents at Stockholm Corporate Finance 15th Life Science Capital Markets Days | Inhalation Sciences AB (publ) presents at Stockholm Corporate Finance 15th Life Science Capital Markets Days
Tue, Mar 07, 2023 12:00 CET Report this content
Inhalation Sciences will take part in the Stockholm Corporate Finance 15th Life Sci... |
| 07.03.2023 | Inhalation Sciences receives IRS order worth 118,464 Euro from US client following 50,000 Euro deposit | Inhalation Sciences receives IRS order worth 118,464 Euro from US client following 50,000 Euro deposit
Tue, Mar 07, 2023 08:00 CET Report this content
(Stockholm, Sweden, 7 March 2023) On 7 February 2023 Inhalations Sciences AB (ISAB) annou... |
| 28.02.2023 | Inhalation Sciences AB (publ) releases Year-End Report 2022 | Inhalation Sciences AB (publ) releases Year-End Report 2022
Tue, Feb 28, 2023 08:00 CET Report this content
(Stockholm, Sweden, 28 February 2023) Inhalation Sciences AB announces that its Year-End Report for 2022 is now available on the com... |
| 07.02.2023 | Inhalation Sciences receives advanced booking payment for upcoming IRS project in April 2023 | Inhalation Sciences receives advanced booking payment for upcoming IRS project in April 2023
Tue, Feb 07, 2023 10:04 CET Report this content
A returning US client of Inhalation Sciences AB (ISAB) will pay a 50,000 Euro deposit to book lab t... |
| 31.01.2023 | Inhalation Sciences receives IRS order worth over 914,000 SEK from new US pharma customer | Inhalation Sciences receives IRS order worth over 914,000 SEK from new US pharma customer
Tue, Jan 31, 2023 08:30 CET Report this content
Inhalation Sciences AB (ISAB) has received an order worth over 914,000 SEK (81,200 Euros) for an Inhal... |
| 12.01.2023 | Join Inhalation Sciences’ CEO and Chairman for Outlook 2023 – post your questions now | Join Inhalation Sciences’ CEO and Chairman for Outlook 2023 – post your questions now
Thu, Jan 12, 2023 10:36 CET Report this content
(Stockholm, Sweden, 12 January 2023) Post your questions to ISAB CEO Manoush Masarrat and Chairman Daniel ... |
| 23.12.2022 | Inhalation Sciences signs R&D order worth 257,000 SEK with major generic pharma company | Inhalation Sciences signs R&D order worth 257,000 SEK with major generic pharma company
Fri, Dec 23, 2022 11:49 CET Report this content
Inhalation Sciences AB (ISAB) has signed a new R&D contract worth 257,000 SEK (23,200 Euros) for... |
| 23.12.2022 | Inhalation Sciences receives IRS order worth 1.9 million SEK with US pharma company | Inhalation Sciences receives IRS order worth 1.9 million SEK with US pharma company
Fri, Dec 23, 2022 11:04 CET Report this content
Inhalation Sciences AB (ISAB) has received an order worth 1.9 MSEK (178,000 Euros) for an Inhalation Researc... |
| 15.12.2022 | DDL2022: Inhalation Sciences had several landmark presentations at well-attended event | DDL2022: Inhalation Sciences had several landmark presentations at well-attended event
Thu, Dec 15, 2022 11:38 CET Report this content
At this year’s DDL in Edinburgh, Scotland (7-9 December) Inhalation Sciences AB (ISAB) presented, for the... |
| 22.11.2022 | Inhalation Sciences AB (publ) releases Q3 Report 2022 | Inhalation Sciences AB (publ) releases Q3 Report 2022
Tue, Nov 22, 2022 08:30 CET Report this content
(Stockholm, Sweden, 22 November 2022) Inhalation Sciences AB announces that its interim report for the third quarter 2022 is now available... |
| 14.11.2022 | Inhalation Sciences begins planned FDA BAA dissolution research project | Inhalation Sciences begins planned FDA BAA dissolution research project
Mon, Nov 14, 2022 08:30 CET Report this content
(Stockholm, 14 November 2022) In September 2022 Inhalation Sciences Sweden AB (ISAB) was awarded an FDA BAA (Broad Agenc... |
| 28.10.2022 | Inhalation Sciences signs IRS order worth 1.17 million SEK with large generic pharma company | Inhalation Sciences signs IRS order worth 1.17 million SEK with large generic pharma company
Fri, Oct 28, 2022 08:57 CET Report this content
Inhalation Sciences has signed a new contract worth 1.17 million SEK (107,600 Euros) for an Inhalat... |
| 20.09.2022 | Inhalation Sciences to present findings of PreciseInhale clinical study at DDL 2022 | Inhalation Sciences to present findings of PreciseInhale clinical study at DDL 2022
Tue, Sep 20, 2022 08:00 CET Report this content
(Stockholm 20 September 2022) ISAB’s conference paper on its study validating PreciseInhale® for clinical us... |
| 16.09.2022 | Inhalation Sciences receives new order worth 62 000 EURO from University of Vienna | Inhalation Sciences receives new order worth 62 000 EURO from University of Vienna
Fri, Sep 16, 2022 11:01 CET Report this content
(Stockholm, 16 September 2022) Inhalation Sciences AB (ISAB) has received a new order from prestigious return... |
| 15.09.2022 | Inhalation Sciences signs IRS contract worth 1.39 million SEK with new US respiratory pharma client | Inhalation Sciences signs IRS contract worth 1.39 million SEK with new US respiratory pharma client
Thu, Sep 15, 2022 10:41 CET Report this content
ISAB’s contract research organization Inhalation Research Services (IRS), has signed a new c... |
| 15.09.2022 | Inhalation Sciences: clarification to previous press releases (published Jan 18, May 5, Aug 4, 2022) regarding the planned FDA study | Inhalation Sciences: clarification to previous press releases (published Jan 18, May 5, Aug 4, 2022) regarding the planned FDA study
Thu, Sep 15, 2022 09:00 CET Report this content
(Stockholm, 15 September 2022) Inhalation Sciences Sweden A... |
| 05.09.2022 | Inhalation Sciences receives new order worth 360,000 SEK from long-term global pharma client | Inhalation Sciences receives new order worth 360,000 SEK from long-term global pharma client
Mon, Sep 05, 2022 08:01 CET Report this content
(Stockholm, 5 September 2022) Inhalation Sciences AB (ISAB) has received a purchase order worth 360... |
| 29.08.2022 | Inhalation Sciences AB (publ) releases Q2 Report 2022 | Inhalation Sciences AB (publ) releases Q2 Report 2022
Mon, Aug 29, 2022 08:00 CET Report this content
(Stockholm, Sweden, 29 August 2022) Inhalation Sciences AB announces that its interim report for the second quarter 2022, January 1 – June... |
| 04.08.2022 | Inhalation Sciences receives landmark FDA approval for co-financing of its study to validate DissolvIt as a standard research method in the US | Inhalation Sciences receives landmark FDA approval for co-financing of its study to validate DissolvIt as a standard research method in the US
Thu, Aug 04, 2022 10:22 CET Report this content
(Stockholm, 4 August 2022) The US FDA (Food and D... |
| 29.06.2022 | PreciseInhale delivers high precision and novel results in new study on inhaled household pollutant in Journal of Environmental Science and Pollution Research | PreciseInhale delivers high precision and novel results in new study on inhaled household pollutant in Journal of Environmental Science and Pollution Research
Wed, Jun 29, 2022 08:30 CET Report this content
(Stockholm 29 June 2022) A new pa... |
| 12.06.2022 | Inhalation Sciences announces outcome of exercise of warrants of series TO 1 | Inhalation Sciences announces outcome of exercise of warrants of series TO 1
Sun, Jun 12, 2022 12:40 CET Report this content
On 3 June 2022, the period for exercising warrants of series TO 1 for subscription of shares in Inhalation Sciences... |
| 09.06.2022 | Inhalation Sciences and RISE collaborate successfully on first proposal for global project on antibiotic resistance | Inhalation Sciences and RISE collaborate successfully on first proposal for global project on antibiotic resistance
Thu, Jun 09, 2022 12:59 CET Report this content
(Stockholm, 9 June 2022) Inhalation Sciences (ISAB) and RISE Research Instit... |
| 24.05.2022 | Inhalation Sciences presents comprehensive new strategy update | Inhalation Sciences presents comprehensive new strategy update
Tue, May 24, 2022 15:57 CET Report this content
(Stockholm, Sweden, 24 May 2022) On 24 May Inhalation Sciences AB presented a major strategy update on its plans and goals for gr... |
| 24.05.2022 | Inhalation Sciences AB secures long-term financing of operations | Inhalation Sciences AB secures long-term financing of operations
Tue, May 24, 2022 11:17 CET Report this content
(Stockholm, Sweden, 24 May 2022) Inhalation Sciences AB has received a credit line from a consortium of lenders of up to SEK 10... |
| 24.05.2022 | Supplement to press release on long-term financing released 24/5 2022 | Supplement to press release on long-term financing released 24/5 2022
Tue, May 24, 2022 16:25 CET Report this content
(Stockholm, Sweden, 24 May 2022) Inhalation Sciences AB has received a credit line from a consortium of lenders of up to S... |
| 23.05.2022 | Inhalation Sciences AB: Subscription price determined for warrants of series TO 1 where the subscription period begins on May 23, 2022. | Inhalation Sciences AB: Subscription price determined for warrants of series TO 1 where the subscription period begins on May 23, 2022.
Mon, May 23, 2022 14:44 CET Report this content
The subscription price in Inhalation Sciences' warrant o... |
| 23.05.2022 | Inhalation Sciences AB (publ) releases Q1 Report 2022 | Inhalation Sciences AB (publ) releases Q1 Report 2022
Mon, May 23, 2022 08:00 CET Report this content
(Stockholm, Sweden, 23 May 2022) Inhalation Sciences AB announces that its first quarter interim report for January 1 – March 31, 2022 is ... |
| 05.05.2022 | Inhalation Sciences receives positive feedback from FDA, moves onto next stage of process to validate DissolvIt as FDA-recommended standard research method in US | Inhalation Sciences receives positive feedback from FDA, moves onto next stage of process to validate DissolvIt as FDA-recommended standard research method in US
Thu, May 05, 2022 09:17 CET Report this content
(Stockholm, 5 May 2022) Inhala... |
| 12.04.2022 | Inhalation Sciences AB signs new distribution agreement to cover China, Hong Kong and Macau | Inhalation Sciences AB signs new distribution agreement to cover China, Hong Kong and Macau
Tue, Apr 12, 2022 08:30 CET Report this content
(Stockholm, Sverige, 12 April 2022) Inhalation Sciences AB has signed a new distribution with Quanta... |
| 11.04.2022 | Inhalation Sciences Sweden AB (publ) releases Annual Report 2021 | Inhalation Sciences Sweden AB (publ) releases Annual Report 2021
Mon, Apr 11, 2022 08:30 CET Report this content
(Stockholm, Sverige, 11 April 2022) Inhalation Sciences AB announces that its Annual Report 2021 is now available on the compan... |
| 11.04.2022 | Inhalation Sciences AB signs new distribution agreement with leading UK Labtech supplier | Inhalation Sciences AB signs new distribution agreement with leading UK Labtech supplier
Mon, Apr 11, 2022 15:18 CET Report this content
(Stockholm, Sverige, 11 April 2022) Inhalation Sciences AB has signed a new distribution agreement with... |
| 18.03.2022 | Inhalation Research Services signs new order worth 74 000 EUR with leading Swiss generics company | Inhalation Research Services signs new order worth 74 000 EUR with leading Swiss generics company
Fri, Mar 18, 2022 08:15 CET Report this content
(Stockholm, 18 March 2022) Inhalation Research Services (IRS) has signed a contract worth 74 0... |
| 04.03.2022 | Inhalation Sciences receives new order worth 23 500 Euro from RISE, the Research Institute of Sweden | Inhalation Sciences receives new order worth 23 500 Euro from RISE, the Research Institute of Sweden
Fri, Mar 04, 2022 08:30 CET Report this content
(Stockholm, 4 March 2022) Inhalation Sciences (ISAB) has received a new order worth 23 500 ... |
| 28.02.2022 | Inhalation Sciences Sweden AB (publ) releases Year-end Report January 1 – 31 December 2021 | Inhalation Sciences Sweden AB (publ) releases Year-end Report January 1 – 31 December 2021
Mon, Feb 28, 2022 08:00 CET Report this content
(Stockholm, Sverige, 28 February 2022) Inhalation Sciences AB announces that its Year-end Report 1 Ja... |
| 14.02.2022 | Inhalation Sciences upgrades Quality Management System to further strengthen company and prepare for increased market requirements | Inhalation Sciences upgrades Quality Management System to further strengthen company and prepare for increased market requirements
Mon, Feb 14, 2022 08:30 CET Report this content
(Stockholm, 14 February 2022) Inhalation Sciences (ISAB) is u... |
| 18.01.2022 | Inhalation Sciences submits whitepaper to FDA aiming to establish DissolvIt® as an FDA-recommended standard research method in US | Inhalation Sciences submits whitepaper to FDA aiming to establish DissolvIt® as an FDA-recommended standard research method in US Tue, Jan 18, 2022 08:20 CET
(Stockholm, 17 January 2022) Inhalation Sciences (ISAB) has submitted a white pape... |
| 20.12.2021 | Positive study results confirm the unique capability of using PreciseInhale in a clinical setting | Positive study results confirm the unique capability of using PreciseInhale in a clinical setting Mon, Dec 20, 2021 08:50 CET
(Stockholm, 20 December, 2021) Results from a recently completed clinical study demonstrate that PreciseInhale® ha... |
| 08.12.2021 | Inhalation Research Services receives order for new joint research project between Chiesi and Karolinska Institutet | Inhalation Research Services receives order for new joint research project between Chiesi and Karolinska Institutet Wed, Dec 08, 2021 10:34 CET
(Stockholm, 8 December 2021) Inhalation Research Services (IRS), the contract research organizat... |
| 25.11.2021 | Inhalation Sciences receives US Registered Trademarks for core aerosol technology | Inhalation Sciences receives US Registered Trademarks for core aerosol technology Thu, Nov 25, 2021 11:36 CET
(Stockholm, Sweden, 25 November, 2021) Inhalation Sciences AB (ISAB) has received Registered Trademarks in the US for PreciseInhal... |
| 24.11.2021 | Inhalation Sciences Sweden AB (publ) releases Q3 Report 2021 | (Stockholm, Sweden, 24 November, 2021) Inhalation Sciences AB announces that the company's Q3 Report for 2021 (in Swedish) is now available on the company's website. For more information please visit: http://inhalation.se/investors/finansie... |
